{"id":339798,"date":"2025-08-19T18:54:25","date_gmt":"2025-08-19T18:54:25","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-jaguar-health\/"},"modified":"2025-08-19T18:54:25","modified_gmt":"2025-08-19T18:54:25","slug":"how-to-buy-jaguar-health","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/","title":{"rendered":"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-339798","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Jaguar Health, Inc. (JAGX) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. G\u00fcncel fiyat trendlerini, risk analizini ve JAGX hissesi i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131n\u0131 ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Jaguar Health, Inc. (JAGX) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. G\u00fcncel fiyat trendlerini, risk analizini ve JAGX hissesi i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131n\u0131 ke\u015ffedin."},"intro":"Nadir hastal\u0131k tedavileriyle ses getiren bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Jaguar Health, Inc. (JAGX), ila\u00e7 sekt\u00f6r\u00fcne bakan yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici bir f\u0131rsat sunuyor. Bu \u015firket, gastrointestinal rahats\u0131zl\u0131klar i\u00e7in bitki bazl\u0131 re\u00e7eteli ila\u00e7lar konusunda uzmanla\u015fm\u0131\u015ft\u0131r ve son klinik at\u0131l\u0131mlar, onu risk ve potansiyel \u00f6d\u00fcl aras\u0131nda ilgin\u00e7 bir kav\u015fa\u011fa yerle\u015ftirmi\u015ftir.","intro_source":{"label":"Intro","type":"text","formatted_value":"Nadir hastal\u0131k tedavileriyle ses getiren bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Jaguar Health, Inc. (JAGX), ila\u00e7 sekt\u00f6r\u00fcne bakan yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici bir f\u0131rsat sunuyor. Bu \u015firket, gastrointestinal rahats\u0131zl\u0131klar i\u00e7in bitki bazl\u0131 re\u00e7eteli ila\u00e7lar konusunda uzmanla\u015fm\u0131\u015ft\u0131r ve son klinik at\u0131l\u0131mlar, onu risk ve potansiyel \u00f6d\u00fcl aras\u0131nda ilgin\u00e7 bir kav\u015fa\u011fa yerle\u015ftirmi\u015ftir."},"body_html":"<h2>\ud83d\udcc8 Jaguar Health Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>19 A\u011fustos 2025 itibar\u0131yla Jaguar Health, Inc. (JAGX), NASDAQ borsas\u0131nda <strong>2,07 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. Takviminize not edin: <strong>Kas\u0131m 2025<\/strong> kesinlikle kritik bir d\u00f6nemdir\u2014\u00e7\u00fcnk\u00fc Jaguar Health bir sonraki kazan\u00e7 raporunu o zaman a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyreklik duyurular \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p> <p><strong>Kazan\u00e7 Raporlar\u0131 JAGX Hissesini Genellikle Nas\u0131l Hareket Ettirir<\/strong><\/p> <p>14 A\u011fustos 2025'teki en son kazan\u00e7lar, hissenin finansal sonu\u00e7lara olan hassasiyetini g\u00f6sterdi. Gelirler ard\u0131\u015f\u0131k olarak %35 artarak 3,0 milyon $'a y\u00fckselirken (<a href=\"https:\/\/www.nasdaq.com\/press-release\/jaguar-health-reports-second-quarter-2025-financials-net-q2-2025-revenue\">2025 2. \u00c7eyrek Raporu<\/a>), net zarar\u0131n 10,4 milyon $'a geni\u015flemesi piyasa tepkilerinde kar\u0131\u015f\u0131kl\u0131\u011fa yol a\u00e7t\u0131.<\/p> <p>Tarihsel desen: JAGX genellikle kazan\u00e7 duyurular\u0131 etraf\u0131nda <strong>%10-18 fiyat dalgalanmalar\u0131<\/strong> ya\u015far, bu da bu d\u00f6nemleri hem riskli hem de potansiyel olarak \u00f6d\u00fcllendirici k\u0131lar.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd0d Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalarla Dolu Bir S\u00fcr\u00fc\u015f<\/h2> <p>Jaguar Health hisseleri son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 ola\u011fan\u00fcst\u00fc bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p> <ul> <li><strong>Ocak 2025<\/strong>: 19,46 $-33,25 $ aras\u0131nda i\u015flem g\u00f6r\u00fcrken, hisse g\u00fc\u00e7l\u00fc ba\u015flad\u0131 ancak ay\u0131 <strong>%12,44 d\u00fc\u015f\u00fc\u015fle<\/strong> kapatt\u0131 (<a href=\"https:\/\/stockscan.io\/stocks\/JAGX\/price-history\">StockScan Verileri<\/a>)<\/li> <li><strong>\u015eubat 2025<\/strong>: 14,21 $-25,75 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rmeye devam ederek ayl\u0131k <strong>%30,26 kay\u0131p<\/strong> ya\u015fad\u0131<\/li> <li><strong>Mart 2025<\/strong>: Dramatik h\u0131zlanma\u2014fiyatlar 21 Mart'ta 15,75 $'dan 0,23 $'a kadar d\u00fc\u015ft\u00fc, ay sonunda yakla\u015f\u0131k 4,76 $'a toparland\u0131<\/li> <li><strong>Nisan 2025<\/strong>: 4,02 $-7,55 $ aras\u0131nda i\u015flem g\u00f6rerek bir miktar istikrar sa\u011flad\u0131 ve ayl\u0131k <strong>%7,56 kazan\u00e7<\/strong> elde etti<\/li> <li><strong>Mevcut Durum<\/strong>: 2,07 $ civar\u0131nda i\u015flem g\u00f6r\u00fcyor ve 52 haftal\u0131k aral\u0131\u011f\u0131 1,93 $-35,25 $ aras\u0131nda, Ocak zirvesinden %93'ten fazla d\u00fc\u015f\u00fc\u015f\u00fc temsil ediyor<\/li> <\/ul> <p>Bu volatilite, klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici kararlar\u0131n bir \u015firketin de\u011ferlemesini bir gecede yap\u0131p bozabilece\u011fi biyoteknoloji yat\u0131r\u0131mlar\u0131ndaki riskleri ve f\u0131rsatlar\u0131 vurgulamaktad\u0131r.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: Mevcut analist konsens\u00fcs\u00fc, medyan fiyat hedefi olarak <strong>28,00 $<\/strong> \u00f6ng\u00f6r\u00fcyor (<a href=\"https:\/\/tickernerd.com\/stock\/jagx-forecast\/\">Tickernerd Analizi<\/a>), bu da %1.250'nin \u00fczerinde potansiyel art\u0131\u015f anlam\u0131na geliyor. Ancak \u015firketin mevcut finansal zorluklar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, daha muhafazakar bir aral\u0131k olan <strong>3-5 $<\/strong> ger\u00e7ek\u00e7i g\u00f6r\u00fcn\u00fcyor \u2192 <strong>TUT\/Temkinli AL<\/strong><\/li> <li><strong>2026 Projeksiyonu<\/strong>: Klinik denemeler ba\u015far\u0131l\u0131 ilerler ve FDA onaylar\u0131 ger\u00e7ekle\u015firse, fiyatlar <strong>8-12 $<\/strong> aral\u0131\u011f\u0131na ula\u015fabilir<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: Pazar geni\u015flemesi ve ba\u015far\u0131l\u0131 ila\u00e7 ticarile\u015ftirmesi ile JAGX <strong>15-25 $<\/strong> aral\u0131\u011f\u0131nda i\u015flem g\u00f6rebilir<\/li> <li><strong>2030 Vizyonu<\/strong>: Birden fazla onayl\u0131 endikasyonla uzun vadeli ba\u015far\u0131, hisseleri <strong>30-40 $<\/strong> seviyelerine ta\u015f\u0131yabilir, ancak bu olduk\u00e7a spek\u00fclatiftir<\/li> <\/ul> <p><strong>Karar<\/strong>: A\u015f\u0131r\u0131 volatilite ve biyoteknoloji sonu\u00e7lar\u0131n\u0131n ikili do\u011fas\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, bu hisse yaln\u0131zca sekt\u00f6r\u00fc anlayan ve riski tolere edebilen yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Finansal S\u00fcrd\u00fcr\u00fclebilirlik<\/strong>: Faaliyet zararlar\u0131 geni\u015flemeye devam ediyor (2025 2. \u00c7eyrek 10,4M $ vs ge\u00e7en y\u0131l 9,5M $)<\/li> <li><strong>D\u00fczenleyici Belirsizlik<\/strong>: FDA onay s\u00fcre\u00e7leri \u00f6ng\u00f6r\u00fclemez ve zaman al\u0131c\u0131d\u0131r<\/li> <li><strong>Nakit T\u00fcketimi<\/strong>: Y\u00fcksek Ar-Ge ve SG&A maliyetleri ek finansman olmadan operasyonlar\u0131 tehdit ediyor<\/li> <li><strong>Piyasa Volatilitesi<\/strong>: Ocak zirvesinden %93 d\u00fc\u015f\u00fc\u015f a\u015f\u0131r\u0131 fiyat hassasiyetini g\u00f6steriyor<\/li> <li><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketleri rakip tedaviler geli\u015ftirebilir<\/li> <\/ul> <h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Klinik At\u0131l\u0131mlar<\/strong>: Crofelemer, MVID hastalar\u0131nda TPN gereksinimlerini %27 azaltt\u0131 (<a href=\"https:\/\/www.stocktitan.net\/news\/JAGX\/jaguar-health-reports-second-quarter-2025-financials-net-q2-2025-sia6cb0i1aid.html\">Klinik Sonu\u00e7lar<\/a>)<\/li> <li><strong>Orphan \u0130la\u00e7 Potansiyeli<\/strong>: MVID i\u00e7in onayl\u0131 tedavi yok\u2014b\u00fcy\u00fck kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7<\/li> <li><strong>FDA \u0130leti\u015fimi<\/strong>: H\u0131zland\u0131r\u0131lm\u0131\u015f d\u00fczenleyici yollar i\u00e7in planlanm\u0131\u015f toplant\u0131lar<\/li> <li><strong>Gelir B\u00fcy\u00fcmesi<\/strong>: %35 ard\u0131\u015f\u0131k gelir art\u0131\u015f\u0131 ticari ivmeyi g\u00f6steriyor<\/li> <li><strong>Pazar Tekeli<\/strong>: Onaylan\u0131rsa potansiyel 7 y\u0131ll\u0131k yetim ila\u00e7 tekel hakk\u0131<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <p><strong>Ciddi \u00d6neriler:<\/strong><\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'sinden fazlas\u0131n\u0131 y\u00fcksek riskli biyotek hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine, zaman i\u00e7inde k\u00fc\u00e7\u00fck al\u0131mlar yaparak zamanlama riskini azalt\u0131n<\/li> <li><strong>Stop-Loss Ayarlay\u0131n<\/strong>: Sermayenizi \u00f6nceden belirlenmi\u015f seviyelerde otomatik sat\u0131\u015f emirleriyle koruyun<\/li> <\/ol> <p><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: \"JAGX ticareti, ya Nobel \u00d6d\u00fcl\u00fc kazanacak ya da gelecek ay ailesinin yan\u0131na d\u00f6necek biriyle \u00e7\u0131kmak gibidir. Her iki durumda da unutulmaz olacak!\"<\/p> <h2>\u2705 Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ listeleri sunan ve makul komisyon \u00fccretlerine sahip oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n<\/td><td>Genellikle temel ki\u015fisel bilgilerle 15 dakika s\u00fcrer<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>Bankan\u0131zdan para transfer edin\u2014kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>JAGX'i \u0130yice Ara\u015ft\u0131r\u0131n<\/td><td>\u015eirketin finansallar\u0131n\u0131, \u00fcr\u00fcn hatt\u0131n\u0131 ve risklerini anlay\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Limit Emirleri Kullan\u0131n<\/td><td>Piyasa emirleri yerine maksimum sat\u0131n alma fiyat\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc \u0130zleyin<\/td><td>JAGX'i portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesi olarak tutun<\/td><\/tr> <tr><td>7<\/td><td>Fiyat Uyar\u0131lar\u0131 Ayarlay\u0131n<\/td><td>\u00d6nemli fiyat hareketleri veya haber olaylar\u0131 hakk\u0131nda bildirim al\u0131n<\/td><\/tr> <tr><td>8<\/td><td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td><td>Kazan\u00e7 raporlar\u0131n\u0131 ve klinik g\u00fcncellemeleri d\u00fczenli okuyun<\/td><\/tr> <tr><td>9<\/td><td>Vergi Etkilerini D\u00fc\u015f\u00fcn\u00fcn<\/td><td>Kar pay\u0131 muamelesi i\u00e7in tutma s\u00fcrelerini anlay\u0131n<\/td><\/tr> <tr><td>10<\/td><td>Bir \u00c7\u0131k\u0131\u015f Stratejisi Belirleyin<\/td><td>K\u00e2r alaca\u011f\u0131n\u0131z veya zarar kesece\u011finiz zaman\u0131 sat\u0131n almadan \u00f6nce bilin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Hisse senedi ticaretine ad\u0131m atmak isteyenler i\u00e7in Pocket Option, ba\u015flamay\u0131 kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile ger\u00e7ek para ile stratejileri test etmeye ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek bir belge ile 1 dakikal\u0131k KYC s\u00fcreci sizi h\u0131zl\u0131ca ticarete ba\u015flat\u0131r<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel banka transferleri dahil 100'den fazla y\u00f6ntem<\/li> <li><strong>Kullan\u0131c\u0131 Dostu Platform<\/strong>: Yeni ba\u015flayanlar i\u00e7in karma\u015f\u0131kl\u0131ktan uzak sezgisel aray\u00fcz<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, JAGX gibi hisselerde k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p piyasa dinamiklerini \u00f6\u011frenmek isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Jaguar Health: Biyoteknolojinin \u0130lgi \u00c7ekici Yar\u0131\u015fmac\u0131s\u0131<\/h2> <p>Jaguar Health, bitki bazl\u0131 re\u00e7eteli ila\u00e7lar geli\u015ftirmeye odaklanan ila\u00e7 sekt\u00f6r\u00fcnde faaliyet g\u00f6stermektedir. \u015eirketin \u00f6nc\u00fc \u00fcr\u00fcn\u00fc Mytesi\u00ae, HIV ile ili\u015fkili ishal i\u00e7in onaylanm\u0131\u015ft\u0131r, ancak as\u0131l heyecan crofelemer'in nadir pediatrik gastrointestinal bozukluklardaki potansiyelindedir.<\/p> <p>Jaguar, yan kurulu\u015fu Napo Pharmaceuticals arac\u0131l\u0131\u011f\u0131yla crofelemer'i, d\u00fcnya \u00e7ap\u0131nda yakla\u015f\u0131k 500 hastay\u0131 etkileyen ve \u015fu anda onayl\u0131 tedavisi olmayan ultranadir bir durum olan Microvillus Inclusion Disease (MVID) i\u00e7in geli\u015ftirmektedir. \u015eirket, crofelemer'in bu hastalarda parenteral beslenme gereksinimlerini %27'ye kadar azaltt\u0131\u011f\u0131n\u0131 g\u00f6steren \u00e7\u0131\u011f\u0131r a\u00e7an klinik veriler sunmu\u015ftur.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Jaguar Health'in ara\u015ft\u0131rma ekibi, Croton lechleri a\u011fac\u0131n\u0131n k\u0131rm\u0131z\u0131 \u00f6zsuyundan elde edilen crofelemer'in, Amazon yerlileri taraf\u0131ndan y\u00fczy\u0131llard\u0131r sindirim sorunlar\u0131n\u0131 tedavi etmek i\u00e7in kullan\u0131ld\u0131\u011f\u0131n\u0131 ke\u015ffetmi\u015ftir\u2014antik geleneksel t\u0131bb\u0131 modern farmas\u00f6tik bilimle harmanlamaktad\u0131r.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Jaguar Health Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>19 A\u011fustos 2025 itibar\u0131yla Jaguar Health, Inc. (JAGX), NASDAQ borsas\u0131nda <strong>2,07 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. Takviminize not edin: <strong>Kas\u0131m 2025<\/strong> kesinlikle kritik bir d\u00f6nemdir\u2014\u00e7\u00fcnk\u00fc Jaguar Health bir sonraki kazan\u00e7 raporunu o zaman a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyreklik duyurular \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p>\n<p><strong>Kazan\u00e7 Raporlar\u0131 JAGX Hissesini Genellikle Nas\u0131l Hareket Ettirir<\/strong><\/p>\n<p>14 A\u011fustos 2025&#8217;teki en son kazan\u00e7lar, hissenin finansal sonu\u00e7lara olan hassasiyetini g\u00f6sterdi. Gelirler ard\u0131\u015f\u0131k olarak %35 artarak 3,0 milyon $&#8217;a y\u00fckselirken (<a href=\"https:\/\/www.nasdaq.com\/press-release\/jaguar-health-reports-second-quarter-2025-financials-net-q2-2025-revenue\">2025 2. \u00c7eyrek Raporu<\/a>), net zarar\u0131n 10,4 milyon $&#8217;a geni\u015flemesi piyasa tepkilerinde kar\u0131\u015f\u0131kl\u0131\u011fa yol a\u00e7t\u0131.<\/p>\n<p>Tarihsel desen: JAGX genellikle kazan\u00e7 duyurular\u0131 etraf\u0131nda <strong>%10-18 fiyat dalgalanmalar\u0131<\/strong> ya\u015far, bu da bu d\u00f6nemleri hem riskli hem de potansiyel olarak \u00f6d\u00fcllendirici k\u0131lar.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd0d Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalarla Dolu Bir S\u00fcr\u00fc\u015f<\/h2>\n<p>Jaguar Health hisseleri son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 ola\u011fan\u00fcst\u00fc bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p>\n<ul>\n<li><strong>Ocak 2025<\/strong>: 19,46 $-33,25 $ aras\u0131nda i\u015flem g\u00f6r\u00fcrken, hisse g\u00fc\u00e7l\u00fc ba\u015flad\u0131 ancak ay\u0131 <strong>%12,44 d\u00fc\u015f\u00fc\u015fle<\/strong> kapatt\u0131 (<a href=\"https:\/\/stockscan.io\/stocks\/JAGX\/price-history\">StockScan Verileri<\/a>)<\/li>\n<li><strong>\u015eubat 2025<\/strong>: 14,21 $-25,75 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rmeye devam ederek ayl\u0131k <strong>%30,26 kay\u0131p<\/strong> ya\u015fad\u0131<\/li>\n<li><strong>Mart 2025<\/strong>: Dramatik h\u0131zlanma\u2014fiyatlar 21 Mart&#8217;ta 15,75 $&#8217;dan 0,23 $&#8217;a kadar d\u00fc\u015ft\u00fc, ay sonunda yakla\u015f\u0131k 4,76 $&#8217;a toparland\u0131<\/li>\n<li><strong>Nisan 2025<\/strong>: 4,02 $-7,55 $ aras\u0131nda i\u015flem g\u00f6rerek bir miktar istikrar sa\u011flad\u0131 ve ayl\u0131k <strong>%7,56 kazan\u00e7<\/strong> elde etti<\/li>\n<li><strong>Mevcut Durum<\/strong>: 2,07 $ civar\u0131nda i\u015flem g\u00f6r\u00fcyor ve 52 haftal\u0131k aral\u0131\u011f\u0131 1,93 $-35,25 $ aras\u0131nda, Ocak zirvesinden %93&#8217;ten fazla d\u00fc\u015f\u00fc\u015f\u00fc temsil ediyor<\/li>\n<\/ul>\n<p>Bu volatilite, klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici kararlar\u0131n bir \u015firketin de\u011ferlemesini bir gecede yap\u0131p bozabilece\u011fi biyoteknoloji yat\u0131r\u0131mlar\u0131ndaki riskleri ve f\u0131rsatlar\u0131 vurgulamaktad\u0131r.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: Mevcut analist konsens\u00fcs\u00fc, medyan fiyat hedefi olarak <strong>28,00 $<\/strong> \u00f6ng\u00f6r\u00fcyor (<a href=\"https:\/\/tickernerd.com\/stock\/jagx-forecast\/\">Tickernerd Analizi<\/a>), bu da %1.250&#8217;nin \u00fczerinde potansiyel art\u0131\u015f anlam\u0131na geliyor. Ancak \u015firketin mevcut finansal zorluklar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, daha muhafazakar bir aral\u0131k olan <strong>3-5 $<\/strong> ger\u00e7ek\u00e7i g\u00f6r\u00fcn\u00fcyor \u2192 <strong>TUT\/Temkinli AL<\/strong><\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: Klinik denemeler ba\u015far\u0131l\u0131 ilerler ve FDA onaylar\u0131 ger\u00e7ekle\u015firse, fiyatlar <strong>8-12 $<\/strong> aral\u0131\u011f\u0131na ula\u015fabilir<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: Pazar geni\u015flemesi ve ba\u015far\u0131l\u0131 ila\u00e7 ticarile\u015ftirmesi ile JAGX <strong>15-25 $<\/strong> aral\u0131\u011f\u0131nda i\u015flem g\u00f6rebilir<\/li>\n<li><strong>2030 Vizyonu<\/strong>: Birden fazla onayl\u0131 endikasyonla uzun vadeli ba\u015far\u0131, hisseleri <strong>30-40 $<\/strong> seviyelerine ta\u015f\u0131yabilir, ancak bu olduk\u00e7a spek\u00fclatiftir<\/li>\n<\/ul>\n<p><strong>Karar<\/strong>: A\u015f\u0131r\u0131 volatilite ve biyoteknoloji sonu\u00e7lar\u0131n\u0131n ikili do\u011fas\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, bu hisse yaln\u0131zca sekt\u00f6r\u00fc anlayan ve riski tolere edebilen yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Finansal S\u00fcrd\u00fcr\u00fclebilirlik<\/strong>: Faaliyet zararlar\u0131 geni\u015flemeye devam ediyor (2025 2. \u00c7eyrek 10,4M $ vs ge\u00e7en y\u0131l 9,5M $)<\/li>\n<li><strong>D\u00fczenleyici Belirsizlik<\/strong>: FDA onay s\u00fcre\u00e7leri \u00f6ng\u00f6r\u00fclemez ve zaman al\u0131c\u0131d\u0131r<\/li>\n<li><strong>Nakit T\u00fcketimi<\/strong>: Y\u00fcksek Ar-Ge ve SG&#038;A maliyetleri ek finansman olmadan operasyonlar\u0131 tehdit ediyor<\/li>\n<li><strong>Piyasa Volatilitesi<\/strong>: Ocak zirvesinden %93 d\u00fc\u015f\u00fc\u015f a\u015f\u0131r\u0131 fiyat hassasiyetini g\u00f6steriyor<\/li>\n<li><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketleri rakip tedaviler geli\u015ftirebilir<\/li>\n<\/ul>\n<h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Klinik At\u0131l\u0131mlar<\/strong>: Crofelemer, MVID hastalar\u0131nda TPN gereksinimlerini %27 azaltt\u0131 (<a href=\"https:\/\/www.stocktitan.net\/news\/JAGX\/jaguar-health-reports-second-quarter-2025-financials-net-q2-2025-sia6cb0i1aid.html\">Klinik Sonu\u00e7lar<\/a>)<\/li>\n<li><strong>Orphan \u0130la\u00e7 Potansiyeli<\/strong>: MVID i\u00e7in onayl\u0131 tedavi yok\u2014b\u00fcy\u00fck kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7<\/li>\n<li><strong>FDA \u0130leti\u015fimi<\/strong>: H\u0131zland\u0131r\u0131lm\u0131\u015f d\u00fczenleyici yollar i\u00e7in planlanm\u0131\u015f toplant\u0131lar<\/li>\n<li><strong>Gelir B\u00fcy\u00fcmesi<\/strong>: %35 ard\u0131\u015f\u0131k gelir art\u0131\u015f\u0131 ticari ivmeyi g\u00f6steriyor<\/li>\n<li><strong>Pazar Tekeli<\/strong>: Onaylan\u0131rsa potansiyel 7 y\u0131ll\u0131k yetim ila\u00e7 tekel hakk\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<p><strong>Ciddi \u00d6neriler:<\/strong><\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2&#8217;sinden fazlas\u0131n\u0131 y\u00fcksek riskli biyotek hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine, zaman i\u00e7inde k\u00fc\u00e7\u00fck al\u0131mlar yaparak zamanlama riskini azalt\u0131n<\/li>\n<li><strong>Stop-Loss Ayarlay\u0131n<\/strong>: Sermayenizi \u00f6nceden belirlenmi\u015f seviyelerde otomatik sat\u0131\u015f emirleriyle koruyun<\/li>\n<\/ol>\n<p><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: &#8220;JAGX ticareti, ya Nobel \u00d6d\u00fcl\u00fc kazanacak ya da gelecek ay ailesinin yan\u0131na d\u00f6necek biriyle \u00e7\u0131kmak gibidir. Her iki durumda da unutulmaz olacak!&#8221;<\/p>\n<h2>\u2705 Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ listeleri sunan ve makul komisyon \u00fccretlerine sahip oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n<\/td>\n<td>Genellikle temel ki\u015fisel bilgilerle 15 dakika s\u00fcrer<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Bankan\u0131zdan para transfer edin\u2014kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>JAGX&#8217;i \u0130yice Ara\u015ft\u0131r\u0131n<\/td>\n<td>\u015eirketin finansallar\u0131n\u0131, \u00fcr\u00fcn hatt\u0131n\u0131 ve risklerini anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit Emirleri Kullan\u0131n<\/td>\n<td>Piyasa emirleri yerine maksimum sat\u0131n alma fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc \u0130zleyin<\/td>\n<td>JAGX&#8217;i portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesi olarak tutun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Fiyat Uyar\u0131lar\u0131 Ayarlay\u0131n<\/td>\n<td>\u00d6nemli fiyat hareketleri veya haber olaylar\u0131 hakk\u0131nda bildirim al\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td>\n<td>Kazan\u00e7 raporlar\u0131n\u0131 ve klinik g\u00fcncellemeleri d\u00fczenli okuyun<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Vergi Etkilerini D\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>Kar pay\u0131 muamelesi i\u00e7in tutma s\u00fcrelerini anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Bir \u00c7\u0131k\u0131\u015f Stratejisi Belirleyin<\/td>\n<td>K\u00e2r alaca\u011f\u0131n\u0131z veya zarar kesece\u011finiz zaman\u0131 sat\u0131n almadan \u00f6nce bilin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Hisse senedi ticaretine ad\u0131m atmak isteyenler i\u00e7in Pocket Option, ba\u015flamay\u0131 kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile ger\u00e7ek para ile stratejileri test etmeye ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek bir belge ile 1 dakikal\u0131k KYC s\u00fcreci sizi h\u0131zl\u0131ca ticarete ba\u015flat\u0131r<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel banka transferleri dahil 100&#8217;den fazla y\u00f6ntem<\/li>\n<li><strong>Kullan\u0131c\u0131 Dostu Platform<\/strong>: Yeni ba\u015flayanlar i\u00e7in karma\u015f\u0131kl\u0131ktan uzak sezgisel aray\u00fcz<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, JAGX gibi hisselerde k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p piyasa dinamiklerini \u00f6\u011frenmek isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Jaguar Health: Biyoteknolojinin \u0130lgi \u00c7ekici Yar\u0131\u015fmac\u0131s\u0131<\/h2>\n<p>Jaguar Health, bitki bazl\u0131 re\u00e7eteli ila\u00e7lar geli\u015ftirmeye odaklanan ila\u00e7 sekt\u00f6r\u00fcnde faaliyet g\u00f6stermektedir. \u015eirketin \u00f6nc\u00fc \u00fcr\u00fcn\u00fc Mytesi\u00ae, HIV ile ili\u015fkili ishal i\u00e7in onaylanm\u0131\u015ft\u0131r, ancak as\u0131l heyecan crofelemer&#8217;in nadir pediatrik gastrointestinal bozukluklardaki potansiyelindedir.<\/p>\n<p>Jaguar, yan kurulu\u015fu Napo Pharmaceuticals arac\u0131l\u0131\u011f\u0131yla crofelemer&#8217;i, d\u00fcnya \u00e7ap\u0131nda yakla\u015f\u0131k 500 hastay\u0131 etkileyen ve \u015fu anda onayl\u0131 tedavisi olmayan ultranadir bir durum olan Microvillus Inclusion Disease (MVID) i\u00e7in geli\u015ftirmektedir. \u015eirket, crofelemer&#8217;in bu hastalarda parenteral beslenme gereksinimlerini %27&#8217;ye kadar azaltt\u0131\u011f\u0131n\u0131 g\u00f6steren \u00e7\u0131\u011f\u0131r a\u00e7an klinik veriler sunmu\u015ftur.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Jaguar Health&#8217;in ara\u015ft\u0131rma ekibi, Croton lechleri a\u011fac\u0131n\u0131n k\u0131rm\u0131z\u0131 \u00f6zsuyundan elde edilen crofelemer&#8217;in, Amazon yerlileri taraf\u0131ndan y\u00fczy\u0131llard\u0131r sindirim sorunlar\u0131n\u0131 tedavi etmek i\u00e7in kullan\u0131ld\u0131\u011f\u0131n\u0131 ke\u015ffetmi\u015ftir\u2014antik geleneksel t\u0131bb\u0131 modern farmas\u00f6tik bilimle harmanlamaktad\u0131r.<\/p>\n"},"faq":[{"question":"Jaguar Health, Inc. (JAGX) hisseleri nereden al\u0131nabilir?","answer":"JAGX hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Jaguar Health hisseleri ne kadar risklidir?","answer":"Biyoteknoloji sekt\u00f6r\u00fc y\u00fcksek volatiliteye sahiptir ve JAGX hisseleri \u00f6zellikle klinik deneme sonu\u00e7lar\u0131na ve d\u00fczenleyici onaylara ba\u011fl\u0131 olarak b\u00fcy\u00fck fiyat dalgalanmalar\u0131 ya\u015fayabilir."},{"question":"Jaguar Health'in ana \u00fcr\u00fcn\u00fc nedir?","answer":"\u015eirketin \u00f6nc\u00fc \u00fcr\u00fcn\u00fc Mytesi\u00ae HIV ile ili\u015fkili ishal i\u00e7in onaylanm\u0131\u015ft\u0131r. Ayr\u0131ca crofelemer adl\u0131 ila\u00e7, nadir gastrointestinal hastal\u0131klar i\u00e7in geli\u015ftirilmektedir."},{"question":"Jaguar Health hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistlerin 2025 y\u0131l sonu i\u00e7in medyan fiyat hedefi yakla\u015f\u0131k 28 $ civar\u0131ndad\u0131r, ancak mevcut finansal zorluklar nedeniyle daha muhafazakar bir aral\u0131k olan 3-5 $ da olas\u0131d\u0131r."},{"question":"Yeni ba\u015flayan biri JAGX hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesiyle ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yap\u0131n, stop-loss emirleri kullan\u0131n ve d\u00fczenli olarak \u015firketin finansal raporlar\u0131n\u0131 takip edin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Jaguar Health, Inc. (JAGX) hisseleri nereden al\u0131nabilir?","answer":"JAGX hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Jaguar Health hisseleri ne kadar risklidir?","answer":"Biyoteknoloji sekt\u00f6r\u00fc y\u00fcksek volatiliteye sahiptir ve JAGX hisseleri \u00f6zellikle klinik deneme sonu\u00e7lar\u0131na ve d\u00fczenleyici onaylara ba\u011fl\u0131 olarak b\u00fcy\u00fck fiyat dalgalanmalar\u0131 ya\u015fayabilir."},{"question":"Jaguar Health'in ana \u00fcr\u00fcn\u00fc nedir?","answer":"\u015eirketin \u00f6nc\u00fc \u00fcr\u00fcn\u00fc Mytesi\u00ae HIV ile ili\u015fkili ishal i\u00e7in onaylanm\u0131\u015ft\u0131r. Ayr\u0131ca crofelemer adl\u0131 ila\u00e7, nadir gastrointestinal hastal\u0131klar i\u00e7in geli\u015ftirilmektedir."},{"question":"Jaguar Health hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistlerin 2025 y\u0131l sonu i\u00e7in medyan fiyat hedefi yakla\u015f\u0131k 28 $ civar\u0131ndad\u0131r, ancak mevcut finansal zorluklar nedeniyle daha muhafazakar bir aral\u0131k olan 3-5 $ da olas\u0131d\u0131r."},{"question":"Yeni ba\u015flayan biri JAGX hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesiyle ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yap\u0131n, stop-loss emirleri kullan\u0131n ve d\u00fczenli olarak \u015firketin finansal raporlar\u0131n\u0131 takip edin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T18:54:25+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-19T18:54:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/\",\"name\":\"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-19T18:54:25+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/","og_locale":"tr_TR","og_type":"article","og_title":"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-19T18:54:25+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-19T18:54:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/","name":"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-19T18:54:25+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-jaguar-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Jaguar Health, Inc. (JAGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Jaguar Health, Inc. (JAGX) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":339803,"slug":"how-to-buy-jaguar-health","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Jaguar Health, Inc. (JAGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Jaguar Health, Inc. (JAGX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-jaguar-health\/"},"pt_AA":{"locale":"pt_AA","id":339805,"slug":"how-to-buy-jaguar-health","post_title":"Como comprar a\u00e7\u00f5es da Jaguar Health, Inc. (JAGX) - Investimento em a\u00e7\u00f5es da Jaguar Health, Inc. (JAGX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-jaguar-health\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/339798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=339798"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/339798\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=339798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=339798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=339798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}